Rare diseases
Investigational molecules
Locations
Evaluation of Upadacitinib for Reducing Ileal Strictures in Patients with Crohn’s Disease
BelgiumMethotrexate tapering versus usual care in elderly (≥70) patients with rheumatoid arthritis in low disease activity – drug combination study
DenmarkSafety and efficacy of stopping versus maintenance dose of filgotinib, tofacitinib and upadacitinib in adult ulcerative colitis patients in deep remission
FranceStudy to evaluate the effect of upadacitinib on the frequency of eye inflammation in patients with axial spondyloarthritis.
BulgariaA study of upadacitinib in adults with erosive mucosal lichen planus and lichen planopilaris.
FranceA study to evaluate the effectiveness of upadacitinib and pirfenidone in reducing symptom severity in patients with Long Covid
ItalyStudy on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment
BelgiumStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
BelgiumA Study of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis Who Did Not Respond Well Enough to Dupilumab Treatment
ItalyStudy on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis
BelgiumStudy on Upadacitinib for Children with Moderate to Severe Crohn's Disease
BelgiumStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
